Search for: "Janssen Research" Results 61 - 80 of 199
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Apr 2011, 5:51 pm by FDABlog HPM
  Linda, who will primarily assist HP&M’s drug development group, brings significant experience and expertise in shaping regulatory policies, particularly Comparative Effectiveness Research, Personalized Medicine, and Evidence-Based Medicine. [read post]
23 Nov 2015, 8:00 am by Robert Kreisman
Janssen Pharmaceuticals Inc., Johnson & Johnson Company and Johnson Pharmaceutical Research and Development, LLC, No. 130401990, Philadelphia County, Court of Common Pleas (Nov. 11, 2015). [read post]
28 Feb 2014, 9:27 pm by Legal Reader
(Hereinafter “Janssen”); (2) Johnson & Johnson; (3) Johnson & Johnson Pharmaceutical Research & Development, L.L.C; (4) Excerpta Medica Inc.; and (5) Elsevier Inc. [read post]
24 Oct 2017, 12:30 pm by Tom Lamb
Future Clinical Trials And Investigations Need To Clarify Whether This Amputation Drug Injury Could Be A Class Effect Of All SGLT2 Inhibitors   (Posted by Tom Lamb at DrugInjuryWatch.com)   During this year we have written several times about the still developing drug safety issue of lower limb amputations linked to Invokana use:  A "Dear Doctor" Letter For Invokana Amputations Side Effect Was Sent September 2017 By Janssen In Canada Analysis Of FDA Adverse Event… [read post]
30 Dec 2015, 9:10 pm
" Contents include:Vincent Bernard, Time to take prevention seriously Interview with Emanuele Castano - Professor and Chair of Psychology, New School for Social Research Knut Dörmann & Jose Serralvo, Common Article 1 to the Geneva Conventions and the obligation to prevent international humanitarian law violations Naz K. [read post]
29 Dec 2016, 8:26 am by Clay Hodges
Despite large amounts of time and money spent on drug and medical device research and development, those drugs and devices don’t always work as intended. [read post]
25 Jan 2016, 6:44 am by Law Offices of Jeffrey S. Glassman
First, it should be noted that researchers at Janssen Pharmaceuticals, which is a wholly owned subsidiary of giant drug manufacturer Johnson & Johnson, conducted this study. [read post]
31 Mar 2012, 2:59 am
"NRDC scientist Sara Janssen expressed disappointment in the agency's decision: "BPA is a toxic chemical that has no place in our food supply. [read post]
10 Feb 2016, 6:51 am by David Jensen
The effort is showing promising results, according to the stem cell agency.Last week, in a sign that ViaCyte has was moving along nicely,  J&J turned over its Janssen BetaLogics group to ViaCyte. [read post]
27 Feb 2014, 12:46 pm
Researchers followed the pediatric subjects beginning from their first trimester in utero for up to 15 years. [read post]
24 Aug 2022, 6:32 am by Levin Papantonio
The research further indicated that other known retinal conditions could, in fact, be artifacts of Elmiron’s toxicity. [read post]
8 Sep 2014, 12:00 am by David Jensen
Last month, the firm announced it had received $20 million (see here and here) from Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson. [read post]
10 Nov 2015, 11:33 am by Tom Lamb
The differing research results for Eliquis and Xarelto mentioned in the final two paragraphs, above, mean that Eliquis may or may not cause fewer dangerous major bleeding events than Xarelto. [read post]
2 Sep 2020, 1:45 pm by Tom Lamb
JOHNSON & JOHNSON d/b/a Alza Corporation, d/b/a Janssen Ortho LLC, d/b/a Janssen Research & Development LLC, d/b/a Ortho-McNeil Pharmaceuticals, Inc. [read post]
23 Jun 2009, 5:47 am
Erick Janssen and Stephanie Sanders, both of the Kinsey Institute. [read post]
18 Jul 2012, 3:58 pm
Unfortunately, some researchers and consumer advocates believe Xarelto may have similar side effects to Pradaxa. [read post]
7 Jul 2011, 10:00 am by Lucas A. Ferrara, Esq.
Xarelto is marketed in the U.S. by Raritan, N.J.- based Janssen Pharmaceuticals, Inc., a member of the Janssen Pharmaceutical Companies of Johnson & Johnson. [read post]